Parmax Pharma Allots 31.37 Lakh Shares And 21.45 Lakh Warrants

Parmax Pharma allotted 31.38 lakh equity shares and 21.45 lakh convertible warrants at ₹36.50 each, including a ₹11.45 crore equity raise. Warrants are exercisable within 18 months, while several allottees are designated as promoters or promoter-group members. Context: completes the previously pending preferential issue in the control-transition plan.